Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study

Psychopharmacology

Volumn 90, Issue 1, 1986, Pages 131-138

  Gram, Lars F ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Antidepressants; Citalopram; Clomipramine; Depression; Serotonin reuptake

Indexed keywords

CITALOPRAM; CLOMIPRAMINE;

ADVERSE DRUG REACTION; ANTICHOLINERGIC EFFECT; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; DRUG TOLERANCE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INTOXICATION; MAJOR CLINICAL STUDY; MOUTH; NAUSEA; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SLEEP DISORDER; SWEATING; THERAPY; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; CLINICAL TRIALS; CLOMIPRAMINE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES; RANDOM ALLOCATION;

EID: 0022448068     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00172884     Document Type: Article

References (32)

1. Correlation of subjective side effects with plasma concentrations of nortriptyline
2. On the methods and theory of reliability
3. The use of rating scales exemplified by a comparison of the Hamilton and the Bech-Rafaelsen Melancholia Scale
4. Quantitative rating of depressive states. Correlation between clinical assessment, self rating scale (Beck's Depression Inventory), and objective rating scale (Hamilton)
5. The WHO depression Scale; Relationship to the Newcastle Scale
6. The Hamilton depression scale; evaluation of specific objectivity using the Rasch-models
7. Assessment of symptom change from improvement curves on the Hamilton Depression Scale in trials with antidepressants
8. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed treated with citalopram. A double-blind comparison of three dose levels
9. The diagnosis of depressive syndromes and the prediction of ECT response
10. Orthostatic side effects of clomipramine and citalopram during treatment for depression
11. Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure discharge
12. Mode of action of antidepressant drugs — primary effects
13. Clincal response and tricyclic plasma levels during treatment with clomipramine
14. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (LU 10-171)
15. Receptors, pharmacokinetics and clinical effects
16. Plasma levels and antidepressive effect of imipramine
17. Imipramine metabolites in blood of patients during therapy and after overdose
18. Clinical studies with femoxetin: a critical review
19. Development of a rating scale for primary depressive illness
20. Experimental pharmacology of selective 5-HT reuptake inhibitors: Differences and similarities
21. Phase-4 studies in psychopharmacology. New antidepressants
22. Therapeutic comparison of selective 5-HT reuptake inhibitors with tricyclic antidepressants
23. Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms
24. Citalopram, a selective serotonin reuptake inhibitor; clinical antidepressive and long term effect — a phase II study
25. Clomipramine: plasma levels and clinical effects
26. Current concepts on the mechanisms of action of antidepressant drugs
27. Cardiovascular effects of imipramine and nortriptyline in elderly patients
28. Plasma levels of clomipramine and its demethyl metabolite during treatment of depression
29. Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response
30. Novel antidepressants and the biogenic amine hypothesis of depression